HIF1A and nonpapillary renal cell carcinoma: For example, in treatment of ccRCC xenografts that are often characterized by a VHL loss of function and results in constitutive expression of HIF1α and HIF2α [66], therapeutic doses of MSC caused a partial downregulation of HIFs with limited antitumor activity.